ArticleBiomedicines2023

Chronic Hepatitis B Relapse Rates after Cessation of Tenofovir Alafenamide and Entecavir Therapy.

Chih-Wen Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.